ALA arovella therapeutics limited

News: ALA Arovella Therapeutics Updates On Ala-101 And Oncarlytics Research Collaboration

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Dec 4 (Reuters) - Arovella Therapeutics Ltd (ALA) :

    • UPDATE ON ALA-101 AND ONCARLYTICS RESEARCH COLLABORATION
    • AVAILABILITY OF PRELIMINARY IN VIVO DATA FOR STUDY DELAYED DUE TO TECHNICAL CHALLENGES
    • DELAY DOES NOT IMPACT PROGRESS OF ALA‐101 TOWARDS FIRST IN HUMAN CLINICAL TRIALS
    • CONTINUES TO COMPLETE MANUFACTURING OPTIMISATION AND SCALE‐UP FOR ALA‐101
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.6¢
Change
0.006(7.50%)
Mkt cap ! $102.8M
Open High Low Value Volume
8.1¢ 8.7¢ 8.1¢ $113.1K 1.345M

Buyers (Bids)

No. Vol. Price($)
1 25000 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 256684 3
View Market Depth
Last trade - 13.37pm 16/09/2025 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.